| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.27 | 0.08 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.08 |